Taken together these studies from our laboratory and from others demonstrate that although VX-325, VX-809 and Corr4a increase F508del-CFTR Cl secretion, these drugs do not modify the hyperinflammatory response of CF airway cells to P. aeruginosa infection. This evidence concerns the gene CFTR and cystic fibrosis.